40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?

Ng Kee Kwong, Koy Chong; Harbham, Pratap K; Selvaraj, Bhuvaneish T; Gregory, Jenna M; Pal, Suvankar; Hardingham, Giles E; Chandran, Siddharthan; Mehta, Arpan R

Ng Kee Kwong, Koy Chong; Harbham, Pratap K; Selvaraj, Bhuvaneish T; Gregory, Jenna M; Pal, Suvankar; Hardingham, Giles E; Chandran, Siddharthan; Mehta, Arpan R.

Afiliação

Ng Kee Kwong KC; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Harbham PK; West Midlands Academic Foundation Programme, University of Birmingham, Birmingham, United Kingdom.
Selvaraj BT; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Gregory JM; UK Dementia Research Institute at University of Edinburgh, Edinburgh, United Kingdom.
Pal S; Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, United Kingdom.
Hardingham GE; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Chandran S; UK Dementia Research Institute at University of Edinburgh, Edinburgh, United Kingdom.
Mehta AR; Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, United Kingdom.

Front Mol Neurosci ; 14: 647895, 2021.

Article em En | MEDLINE | ID: mdl-33815058

Palavras-chave

amyotrophic lateral sclerosis; cerebrospinal fluid; motor neuron disease; neurodegeneration; pathophysiology; toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Mol Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google